Thyrocare Technologies Ltd

Mon 17/08/2026,13:49:58 | NSE : THYROCARE

₹617.50-6.55 (-1.05%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 630.00

Previous Close

₹ 624.05

Volume

209786

Mkt Cap ( ₹ Cr)

₹ 9828.46

High

₹ 630.00

Low

₹ 610.10

52 Week High

₹ 662.00

52 Week Low

₹ 342.55

Book Value Per Share

₹ 36.79

Dividend Yield

2.24

Face Value

₹ 10.00

What's Your Call?

Collective community sentiment on Thyrocare Technologies Ltd

Your Vote -

Buy

78.85%

Hold

7.69%

Sell

13.46%

78.85%

52 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

45%

Sell Order Quantity

55%

Bid Price

Qty

619.05

1

619.00

3

619.00

174

619.00

17

619.00

23

Bid Total

76173

Bid Price

Qty

619.20

725

619.00

42

619.00

21

619.00

16

619.00

26

Bid Total

92590

Option Chain

Analyzes market sentiment, predicts Thyrocare Technologies Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Thyrocare Tech. - Updates

    13 Aug 2026, 10:57AM Thyrocare Technologies Limited has informed the Exchange regarding communication received from Promoter regarding sale of 1,57,69,696 Equity Shares of

  • Thyrocare Tech. - Communication Received From Promoter Regarding Sale Of 1,57,69,696 Equity Shares Of The Company By Promoter

    13 Aug 2026, 10:54AM Please refer the enclosed intimation letter.

  • Thyrocare Tech. - Updates

    13 Aug 2026, 10:24AM Thyrocare Technologies Limited has informed the Exchange regarding a Communication Received From Promoter Regarding Release Of Pledge On 1,75,00,000 E

  • Thyrocare Tech. - Communication Received From Promoter Regarding Release Of Pledge On 1,75,00,000 Equity Shares Of Thyrocare

    13 Aug 2026, 10:21AM Please find the attached disclosure received from Docon Technologies Private Limited (\Promoter\) for release of pledge on equity shares of the Compan

  • Thyrocare Tech. - Analysts/Institutional Investor Meet/Con. Call Updates

    27 Jul 2026, 1:12PM Thyrocare Technologies Limited has informed the Exchange about Earnings Call Transcript held on July 23, 2026

  • Thyrocare Tech. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    27 Jul 2026, 1:08PM Please find attached the Earnings Call Transcript held on July 23, 2026

  • Thyrocare Tech. - Submission Of Machine-Readable Document Of Earlier Submitted Results Of The Company For The Quarter Ended O

    24 Jul 2026, 6:11PM Thyrocare Technologies Limited has informed the exchange regarding submission of machine-readable document of earlier submitted results of the Company

  • Thyrocare Tech. - Updates

    24 Jul 2026, 6:02PM Thyrocare Technologies Limited has informed the Exchange regarding submission of machine-readable document of earlier submitted results of the Company

  • Thyrocare Tech. - Copy of Newspaper Publication

    24 Jul 2026, 12:47PM Thyrocare Technologies Limited has informed the Exchange about Copy of Newspaper Publication of unaudited financial results for the quarter ended June

  • Thyrocare Tech. - Analysts/Institutional Investor Meet/Con. Call Updates

    23 Jul 2026, 7:36PM Please find attached herewith Link of Audio Recording for Investor Call held on July 23, 2026

  • Thyrocare Tech. - Audio Recording Of Earnings Conference Call For The Quarter Ended June 30, 2026

    23 Jul 2026, 7:33PM Audio Recording of Earnings Conference Call for the quarter ended on June 30, 2026

  • Thyrocare Tech. - General Updates

    23 Jul 2026, 4:32PM Please refer the enclosed intimation regarding the in-principle approval of the Board of Directors of the Company for evaluation of the proposed restr

  • Thyrocare Tech. - Appointment

    23 Jul 2026, 4:15PM Thyrocare Technologies Limited has informed the Exchange regarding re-appointment of M/s. Ernst & Young LLP as Internal Auditor of the Company.

  • Thyrocare Tech. - Investor Presentation

    23 Jul 2026, 4:09PM Thyrocare Technologies Limited has informed the Exchange about Investor Presentation

  • Thyrocare Tech. - Press Release

    23 Jul 2026, 4:08PM Thyrocare Technologies Limited has informed the Exchange regarding a press release dated July 23, 2026 on the Unaudited Financial Results (Standalone

  • Thyrocare Tech. - Outcome of Board Meeting

    23 Jul 2026, 3:49PM Outcome of the Board Meeting held on July 23, 2026

  • Thyrocare Tech. - Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations,

    23 Jul 2026, 4:29PM Please refer the enclosed intimation regarding the in-principle approval of the Board of Directors of the Company for evaluation of the proposed restr

  • Thyrocare Tech. - Re-Appointment Of Internal Auditor Of The Company

    23 Jul 2026, 4:12PM Please find attached the Intimation regarding the re-appointment of the Internal Auditor of the Company.

  • Thyrocare Tech. - Announcement under Regulation 30 (LODR)-Investor Presentation

    23 Jul 2026, 4:05PM Please find attached the Investor Presentation on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended on June 30, 2026

  • Thyrocare Tech. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    23 Jul 2026, 4:02PM Please find attached the Press Release on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended on June 30, 2026

  • Thyrocare Tech. - Unaudited Financial Results For The Quarter Ended June 30, 2026

    23 Jul 2026, 3:53PM Please find enclosed the unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30, 2026

  • Thyrocare Tech. - Board Meeting Outcome for Outcome Of The Board Meeting Held On July 23, 2026

    23 Jul 2026, 3:42PM Please find enclosed outcome of the Board Meeting held on July 23, 2026, inter alia, approving the unaudited financial results for the quarter ended J

  • Thyrocare Tech. - Analysts/Institutional Investor Meet/Con. Call Updates

    16 Jul 2026, 1:41PM Thyrocare Technologies Limited has informed the Exchange about Schedule of meet

  • Thyrocare Tech. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    16 Jul 2026, 1:27PM Thyrocare Technologies Limited cordially invites you to its \Earning Call\ to be held on Thursday, July 23, 2026 at 06.00 P.M. to discuss the financia

  • Thyrocare Tech. - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Unaudited Stand

    16 Jul 2026, 12:48PM Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 ,inter alia, to consid

  • Thyrocare Tech. has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    14 Jul 2026, 5:02PM As of June 2026, 60.92% is owned by Indian Promoters and 39.08% by Public. <p align=justify> Institutional holds 26.35% (Insurance Companies 0.12%) an

  • Thyrocare Tech. - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Jul 2026, 12:26PM Thyrocare Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarte

  • Thyrocare Tech. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jul 2026, 12:21PM Please find attached herewith Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter e

  • Thyrocare Tech. - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

    30 Jun 2026, 8:59PM Please find enclosed intimation regarding Amendments to Memorandum of Association of the Company.

  • Thyrocare Tech. - Amendment to AOA/MOA

    30 Jun 2026, 8:57PM Thyrocare Technologies Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.

  • Thyrocare Tech. - Change In Statutory Auditors Of The Company

    30 Jun 2026, 8:54PM Please find enclosed intimation regarding change in Statutory Auditors of the Company

  • Thyrocare Tech. - Change in Auditors

    30 Jun 2026, 8:49PM Thyrocare Technologies Limited has informed the Exchange regarding Change in Auditors of the company.

  • Thyrocare Tech. - Shareholder Meeting / Postal Ballot-Outcome of AGM

    30 Jun 2026, 8:39PM Proceedings of the 26th Annual General Meeting held on 30th June, 2026. Further the scrutinizer's report along with voting results is enclosed.

  • Thyrocare Tech. - Shareholders meeting

    30 Jun 2026, 8:31PM Thyrocare Technologies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on June 30, 2026. Further, the company h

  • Thyrocare Tech. - Trading Window

    24 Jun 2026, 5:57PM Thyrocare Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regula

  • Thyrocare Tech. - Updates

    10 Jun 2026, 9:25PM We are enclosing herewith an intimation regarding communication to Shareholders - Intimation on Tax Deduction on Dividend.

  • Thyrocare Tech. - Communication To Shareholders - Intimation On Tax Deduction On Dividend

    10 Jun 2026, 9:23PM Please find enclosed communication sent to shareholders for deduction of tax on dividend.

  • Thyrocare Tech. has declared 70% Final dividend for the financial year March 2026

    7 Jun 2026, 11:10AM Thyrocare Technologies Ltd. on Thursday, 07 May 2026, has announced Final dividend of 70 percent on Equity Share, to its shareholders holding shares o

  • Thyrocare Tech. - Disclosure under SEBI Takeover Regulations

    5 Jun 2026, 12:39PM Docon Technologies Private Ltd has submitted toÿ the Exchange a copy of disclosure under Regulations, 31(1) and 31(2) of SEBI ( SAST) Regulations, 201

  • Thyrocare Tech. - Copy of Newspaper Publication

    5 Jun 2026, 12:37PM Please find attached herewith copies of Newspaper Publications published on June 05, 2026, in Business Standard (English) and Navshakti (Marathi)

  • Thyrocare Tech. - Letter Sent To Members Of The Company Providing Web Link For AGM Notice And Annual Report For The FY 2025-2

    4 Jun 2026, 10:07PM Please find attached letter sent to members of the Company providing web link for the AGM Notice and Annual report for the FY 2025-26

  • Thyrocare Tech. - General Updates

    4 Jun 2026, 10:03PM Thyrocare Technologies Limited has informed the Exchange about letter sent to Members providing web link of AGM Notice and Annual report for the FY 20

  • Thyrocare Tech. - Updates

    4 Jun 2026, 9:59PM Thyrocare Technologies Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Reporting (BRSR) of the Company for th

  • Thyrocare Tech. - Record Date

    4 Jun 2026, 9:55PM Thyrocare Technologies Limited has informed the Exchange that Record Date for the purpose of Final Dividend for the FY 2025-26 is Tuesday, 23-Jun-202

  • Thyrocare Tech. - Record Date For The Purpose Of Final Dividend For The FY 2025-26 Is Tuesday, June 23, 2026

    4 Jun 2026, 9:36PM Please find attached intimation of Record Date for the purpose of final dividend for the FY 2025-26.

  • Thyrocare Tech. - Business Responsibility and Sustainability Reporting (BRSR)

    4 Jun 2026, 9:29PM Please find attached the Business Responsibility and Sustainability Reporting (BRSR) of the Company for the FY 2025-26

  • Thyrocare Tech. - Reg. 34 (1) Annual Report.

    4 Jun 2026, 9:18PM Please find attached the Annual Report of Thyrocare Technologies Limited for the FY 2025-26.

  • Thyrocare Tech. - Shareholders meeting

    4 Jun 2026, 9:14PM Thyrocare Technologies Limited has informed the Exchange regarding Notice of 26th Annual General Meeting to be held on Jun 30, 2026.

  • Thyrocare Tech. - Notice Of 26Th Annual General Meeting Of Thyrocare Technologies Limited To Be Held On Tuesday, June 30, 202

    4 Jun 2026, 9:10PM Please find attached the Notice of 26th Annual General Meeting along with Annual Report for the FY 2025-26.

  • Thyrocare Tech. - Copy of Newspaper Publication

    26 May 2026, 1:09PM Please find enclosed herewith copies of Newspaper advertisement published on May 25, 2026 in Business Standard (English) and Pratahkal (Marathi).

  • Thyrocare Tech. - Disclosure under SEBI Takeover Regulations

    21 May 2026, 10:49AM Docon Technologies Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of I

  • Thyrocare Technologies Ltd

    29 Jan 2026 , 9:06AM Thyrocare : The company reported a strong performance for the December quarter, with net profit rising 36.7% year-on-year to ₹26.1 crore, compared with ₹19.1 crore in the same period last year, aided by higher volumes and operating leverage. Revenue growth stood at 17.8% at Rs 196 crore versus Rs 166 crore. EBITDA was up 38.6% at Rs 57.8 crore versus Rs 41.7 crore. EBITDA Margins came in at 29.6% versus 25.2% yoy.

  • Thyrocare Technologies

    15 Oct 2025 , 9:04AM Thyrocare Technologies : The company delivered a robust performance for the July-September quarter, with net profit soaring 82% year-on-year to Rs 47.90 crore, driven by a surge in test volumes and enhanced operational efficiency. The company's revenue rose 22%, reaching Rs 216.5 crore, up from Rs 177.4 crore in the same period last year. EBITDA witnessed a sharp 47.5% growth, coming in at Rs 71.3 crore, reflecting strong cost management and scale efficiencies. As a result, operating margins expanded significantly to 32.9%, compared to 27.2% in the year-ago quarter. The board also Ok’d 2:1 bonus share issue proposal. Positive

  • Thyrocare to acquire Vimta's Diagnostic & Pathological svcs business on a slump sale basis

    30 Aug 2024 , 12:00PM Thyrocare Technologies enters into a BTA to acquire diagnostic and pathological services business of Vimta Labs

  • Thyrocare Technologies

    28 Jun 2021 , 9:32AM The promoters and promoters group of the company have entered in to an agreement with Docon Technologies Private Limited (along with API Holdings Pvt Limited – Persons acting in concert) to sell their entire stake of 66.14% representing 3,49,72,999 equity shares in Thyrocare Technologies for a consideration of 4564 crs, translating to RS 1305 per equity share. Consequent to the execution of share purchase agreement, an open offer for acquisition of 1.37 crore shares of Thyrocare, representing 26% of the expanded voting share capital has been announced at a price of Rs 1300 per share, which is at a discount of 10.2% as compared to closing price of Rs 1448 as on 25th June 2021.

  • Thyrocare board approves share buyback

    10 Sep 2018 , 11:56AM Thyrocare Technologies board approved buyback of 8.63 lakh shares at Rs. 730 per share (14% upside from closing on Sep 07,2018) aggregating to Rs. 63 crores; The buyback size is 14.97% of the aggregate paid-up share capital –Positive for Thyrocare; buyback is open only for public shareholders (promoters not allowed); Objective of buyback is to return surplus cash to shareholders.
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Thyrocare Technologies Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 560.68 537.1 533.58 521.04 520.7
Liabilities 560.68 537.1 533.58 521.04 520.7
Equity 159.17 52.99 52.95 52.93 52.9
Gross Profit 256.33 187.02 133.88 112.01 230.83
Net Profit 148.81 95.78 71.14 56.97 152.05
Cash From Operating Activities 206.07 190.76 155.19 120.02 105.68
NPM(%) 19.21 15.12 13.57 11.71 27.07
Revenue 774.27 633.1 524.02 486.46 561.53
Expenses 517.94 446.08 390.14 374.45 330.7
ROE(%) 25.41 16.35 12.15 9.73 25.96

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
23 Jun 2026 7 70 2.27 470.7
24 Oct 2025 7 70 2.27 1264.6
25 Jul 2025 21 210 2.27 769.2
16 Aug 2024 18 180 2.27 647.25
20 Apr 2023 18 180 2.27 475.9
11 May 2022 15 150 2.27 770.95
17 Jun 2021 15 150 2.27 1063.6
12 Nov 2020 10 100 2.27 1137.65
21 Nov 2019 5 50 2.27 558.55
14 Aug 2019 20 200 2.27 434.7
02 Aug 2018 5 50 2.27 668.95
15 Feb 2018 5 50 2.27 676.2
03 Aug 2017 5 50 2.27 735.45
08 Feb 2017 5 50 2.27 709
01 Sep 2016 2.5 25 2.27 602

Peers

Other companies within the same industry or sector that are comparable to Thyrocare Technologies Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 805.90 -0.81 20.38 356.02 -26.19 0.62
Lotus Eye Hospital and Institute Ltd 116.00 0.68 1657.14 1297.27 0.39 0.00
Vaishali Pharma Ltd 8.61 1.18 26.91 8138.23 15.42 0.00
Astec Lifesciences Ltd 587.00 -1.17 0.00 1389.96 -363.14 0.00

Company Info

The Company was incorporated as Thyrocare Technologies Limited on January 28, 2000 at Mumbai as a public limited company under the Companies Act, 1956. the Company was issued a certificate of commencement of business from the RoC on March 7, 2000. Major events and milestones of the Company : 2000 -The Company was incorporated in the name and style of "Thyrocare Technologies Limited' and received a certificate for commencement of operations. 2001 -The Company received ISO 9001 certification. -The Company commenced commercial operations under the brand name 'Thyrocare' pursuant to the acquisition of business of TDPL and TBPL (which were incorporated in 1996). 2005 -The Company received NABL accreditation. 2006 -The Company issued certain fully convertible debentures aggregating to 250 million to BCCL. 2007 -The Company receives accreditation from the College of American Pathologists (CAP). 2010 -The Company issued certain compulsorily convertible debentures aggregating to 250 million to Agalia. Agalia also acquired certain Equity Shares aggregating to 1,250 million from the Promoters and certain other persons. -The Company launched wellness packages under the brand name "Aarogyam". 2011 -The Company migrated to "total laboratory automation system" installed by Siemens for efficient handling of increasing volumes. 2012 -NVP acquired certain Equity Shares aggregating to 1,200 million from certain entities. 2013 -EIF acquired certain Equity Shares from Agalia. -The Subsidiary commenced operations at the PET-CT centres at Navi Mumbai and conducted over 1,000 scans in the first year of operation. 2014 -The Company had installed, India's first and the world's longest track automation system for seamless sample movements from Siemens Limited. -The Company commissioned the operations in medical cyclotron facility in Navi Mumbai. -The Subsidiary commenced operations at the PET-CT centres in New Delhi and Hyderabad and the PET-CT centres at New Delhi conducted over 1,000 scans in the first year of operations. 2015 -The Company opened RPLs in Delhi, Coimbatore, Hyderabad and Kolkata to expand its coverage and volume of tests and samples processed daily. -The Company acquired the equipment for testing of water samples and commenced operating the equipment under the brand name "WHATERS". These tests, at present include physical and chemical testing, elements testing, microbiology testing, pesticide testing and volatile organic compounds testing. -The Subsidiary has completed over 10,000 scans at the PET-CT centres in New Delhi, over 10,000 scans at the PET-CT centres in Navi Mumbai from the date of inception and over 1,000 scans at the PET-CT centres in Hyderabad since inception. 2016 -Thyrocare Technologies are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. 2024 -Thyrocare Technologies Completed acquisition of Think Health Diagnostic Private Limited. 2025-The Company has issued Bonus Shares in the Ratio of 2:1.

The Company was incorporated as Thyrocare Technologies Limited on January 28, 2000 at Mumbai as a public limited company under the Companies Act, 1956. the Company was issued a certificate of commencement of business from the RoC on March 7, 2000. Major events and milestones of the Company : 2000 -The Company was incorporated in the name and style of "Thyrocare Technologies Limited' and received a certificate for commencement of operations. 2001 -The Company received ISO 9001 certification. -The Company commenced commercial operations under the brand name 'Thyrocare' pursuant to the acquisition of business of TDPL and TBPL (which were incorporated in 1996). 2005 -The Company received NABL accreditation. 2006 -The Company issued certain fully convertible debentures aggregating to 250 million to BCCL. 2007 -The Company receives accreditation from the College of American Pathologists (CAP). 2010 -The Company issued certain compulsorily convertible debentures aggregating to 250 million to Agalia. Agalia also acquired certain Equity Shares aggregating to 1,250 million from the Promoters and certain other persons. -The Company launched wellness packages under the brand name "Aarogyam". 2011 -The Company migrated to "total laboratory automation system" installed by Siemens for efficient handling of increasing volumes. 2012 -NVP acquired certain Equity Shares aggregating to 1,200 million from certain entities. 2013 -EIF acquired certain Equity Shares from Agalia. -The Subsidiary commenced operations at the PET-CT centres at Navi Mumbai and conducted over 1,000 scans in the first year of operation. 2014 -The Company had installed, India's first and the world's longest track automation system for seamless sample movements from Siemens Limited. -The Company commissioned the operations in medical cyclotron facility in Navi Mumbai. -The Subsidiary commenced operations at the PET-CT centres in New Delhi and Hyderabad and the PET-CT centres at New Delhi conducted over 1,000 scans in the first year of operations. 2015 -The Company opened RPLs in Delhi, Coimbatore, Hyderabad and Kolkata to expand its coverage and volume of tests and samples processed daily. -The Company acquired the equipment for testing of water samples and commenced operating the equipment under the brand name "WHATERS". These tests, at present include physical and chemical testing, elements testing, microbiology testing, pesticide testing and volatile organic compounds testing. -The Subsidiary has completed over 10,000 scans at the PET-CT centres in New Delhi, over 10,000 scans at the PET-CT centres in Navi Mumbai from the date of inception and over 1,000 scans at the PET-CT centres in Hyderabad since inception. 2016 -Thyrocare Technologies are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. 2024 -Thyrocare Technologies Completed acquisition of Think Health Diagnostic Private Limited. 2025-The Company has issued Bonus Shares in the Ratio of 2:1.

Parent Organisation

Thyrocare Technologies Ltd.

Founded

28/01/2000

Managing Director

NSE Symbol

THYROCAREEQ

FAQ